ID   PLCL2_HUMAN             Reviewed;        1127 AA.
AC   Q9UPR0; A8K5V4; Q8N498; Q9H8L0; Q9UFP9;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   28-JUN-2023, entry version 183.
DE   RecName: Full=Inactive phospholipase C-like protein 2;
DE            Short=PLC-L(2);
DE            Short=PLC-L2;
DE            Short=Phospholipase C-L2;
DE   AltName: Full=Phospholipase C-epsilon-2;
DE            Short=PLC-epsilon-2;
GN   Name=PLCL2; Synonyms=KIAA1092, PLCE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 384-1127 (ISOFORM 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS ARG-211;
RP   MET-635; VAL-742; HIS-809 AND ARG-890.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 918-1127.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-584 AND SER-1113, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; THR-584 AND SER-1113, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-584, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May play an role in the regulation of Ins(1,4,5)P3 around the
CC       endoplasmic reticulum. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UPR0; P22607: FGFR3; NbExp=3; IntAct=EBI-311059, EBI-348399;
CC       Q9UPR0; P06396: GSN; NbExp=3; IntAct=EBI-311059, EBI-351506;
CC       Q9UPR0; P01112: HRAS; NbExp=3; IntAct=EBI-311059, EBI-350145;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Predominantly localized to
CC       perinuclear areas in both myoblast and myotube C2C12 cells.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UPR0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPR0-2; Sequence=VSP_025790, VSP_025791, VSP_025792;
CC       Name=3;
CC         IsoId=Q9UPR0-3; Sequence=VSP_025790;
CC   -!- CAUTION: In the PI-PLC X-box Thr-486 is present instead of the
CC       conserved His which is one of the active site residues. It is therefore
CC       expected that this protein lacks catalytic activity. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA83044.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB14606.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB029015; BAA83044.1; ALT_INIT; mRNA.
DR   EMBL; AK023546; BAB14606.1; ALT_INIT; mRNA.
DR   EMBL; AK291419; BAF84108.1; -; mRNA.
DR   EMBL; BC036392; AAH36392.1; -; mRNA.
DR   EMBL; AL117515; CAB55974.1; -; mRNA.
DR   CCDS; CCDS33713.1; -. [Q9UPR0-3]
DR   CCDS; CCDS74911.1; -. [Q9UPR0-1]
DR   PIR; T17284; T17284.
DR   RefSeq; NP_001137854.1; NM_001144382.1. [Q9UPR0-1]
DR   RefSeq; NP_055999.2; NM_015184.5. [Q9UPR0-3]
DR   RefSeq; XP_016861511.1; XM_017006022.1.
DR   RefSeq; XP_016861512.1; XM_017006023.1.
DR   RefSeq; XP_016861513.1; XM_017006024.1.
DR   RefSeq; XP_016861514.1; XM_017006025.1. [Q9UPR0-3]
DR   AlphaFoldDB; Q9UPR0; -.
DR   SMR; Q9UPR0; -.
DR   BioGRID; 116833; 15.
DR   IntAct; Q9UPR0; 11.
DR   MINT; Q9UPR0; -.
DR   STRING; 9606.ENSP00000478458; -.
DR   GlyGen; Q9UPR0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UPR0; -.
DR   PhosphoSitePlus; Q9UPR0; -.
DR   BioMuta; PLCL2; -.
DR   DMDM; 148880116; -.
DR   EPD; Q9UPR0; -.
DR   jPOST; Q9UPR0; -.
DR   MassIVE; Q9UPR0; -.
DR   MaxQB; Q9UPR0; -.
DR   PaxDb; Q9UPR0; -.
DR   PeptideAtlas; Q9UPR0; -.
DR   ProteomicsDB; 85423; -. [Q9UPR0-1]
DR   ProteomicsDB; 85424; -. [Q9UPR0-2]
DR   ProteomicsDB; 85425; -. [Q9UPR0-3]
DR   Antibodypedia; 26950; 171 antibodies from 29 providers.
DR   DNASU; 23228; -.
DR   Ensembl; ENST00000432376.5; ENSP00000412836.1; ENSG00000154822.18. [Q9UPR0-3]
DR   Ensembl; ENST00000615277.5; ENSP00000478458.1; ENSG00000154822.18. [Q9UPR0-1]
DR   Ensembl; ENST00000638327.1; ENSP00000491897.1; ENSG00000284017.2. [Q9UPR0-3]
DR   Ensembl; ENST00000638466.2; ENSP00000492839.1; ENSG00000284017.2. [Q9UPR0-1]
DR   GeneID; 23228; -.
DR   KEGG; hsa:23228; -.
DR   MANE-Select; ENST00000615277.5; ENSP00000478458.1; NM_001144382.2; NP_001137854.1.
DR   UCSC; uc011awd.3; human. [Q9UPR0-1]
DR   AGR; HGNC:9064; -.
DR   CTD; 23228; -.
DR   DisGeNET; 23228; -.
DR   GeneCards; PLCL2; -.
DR   HGNC; HGNC:9064; PLCL2.
DR   HPA; ENSG00000154822; Tissue enhanced (skeletal).
DR   MIM; 614276; gene.
DR   neXtProt; NX_Q9UPR0; -.
DR   OpenTargets; ENSG00000154822; -.
DR   PharmGKB; PA33395; -.
DR   VEuPathDB; HostDB:ENSG00000154822; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   GeneTree; ENSGT00940000155660; -.
DR   InParanoid; Q9UPR0; -.
DR   OMA; MRTSWIS; -.
DR   OrthoDB; 2900494at2759; -.
DR   PhylomeDB; Q9UPR0; -.
DR   TreeFam; TF313216; -.
DR   PathwayCommons; Q9UPR0; -.
DR   SignaLink; Q9UPR0; -.
DR   BioGRID-ORCS; 23228; 12 hits in 1151 CRISPR screens.
DR   ChiTaRS; PLCL2; human.
DR   GenomeRNAi; 23228; -.
DR   Pharos; Q9UPR0; Tbio.
DR   PRO; PR:Q9UPR0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UPR0; protein.
DR   Bgee; ENSG00000154822; Expressed in cortical plate and 105 other tissues.
DR   ExpressionAtlas; Q9UPR0; baseline and differential.
DR   Genevisible; Q9UPR0; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0050811; F:GABA receptor binding; IDA:MGI.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:InterPro.
DR   GO; GO:0002322; P:B cell proliferation involved in immune response; IEA:Ensembl.
DR   GO; GO:0002337; P:B-1a B cell differentiation; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:InterPro.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:1900122; P:positive regulation of receptor binding; IEA:Ensembl.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   CDD; cd00275; C2_PLC_like; 1.
DR   CDD; cd16223; EFh_PRIP2; 1.
DR   CDD; cd13364; PH_PLC_eta; 1.
DR   CDD; cd08597; PI-PLCc_PRIP_metazoa; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 3.20.20.190; Phosphatidylinositol (PI) phosphodiesterase; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR028382; PLCL2_EFh.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336:SF84; INACTIVE PHOSPHOLIPASE C-LIKE PROTEIN 2; 1.
DR   PANTHER; PTHR10336; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C FAMILY PROTEIN; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF16457; PH_12; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF51695; PLC-like phosphodiesterases; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Phosphoprotein;
KW   Reference proteome; Transducer.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..1127
FT                   /note="Inactive phospholipase C-like protein 2"
FT                   /id="PRO_0000288851"
FT   DOMAIN          141..251
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          426..570
FT                   /note="PI-PLC X-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   DOMAIN          618..734
FT                   /note="PI-PLC Y-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00271"
FT   DOMAIN          734..863
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1101..1127
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        108..125
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1105..1127
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         84
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K394"
FT   MOD_RES         584
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         1..126
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025790"
FT   VAR_SEQ         1069..1086
FT                   /note="GQADLLKYAKNETLENLK -> IRKTGRRSIFVPQTPIMV (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025791"
FT   VAR_SEQ         1087..1127
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025792"
FT   VARIANT         211
FT                   /note="Q -> R (in dbSNP:rs17853614)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032507"
FT   VARIANT         635
FT                   /note="V -> M (in dbSNP:rs17857109)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032508"
FT   VARIANT         742
FT                   /note="A -> V (in dbSNP:rs17857110)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032509"
FT   VARIANT         809
FT                   /note="P -> H (in dbSNP:rs17853612)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032510"
FT   VARIANT         890
FT                   /note="H -> R (in dbSNP:rs17853613)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032511"
SQ   SEQUENCE   1127 AA;  125866 MW;  F75F774DAE18EC5F CRC64;
     MAECGRGGAA GGALPTSPGP ALGAKGALKA GVGEGGGGGG RLGHGRARYD SGGVSNGDCS
     LGVSGDEARA SPTRGPRGVA LAPTPSAVVC TLPRESKPGG LPRRSSIIKD GTKQKRERKK
     TVSFSSMPTE KKISSASDCI NSMVEGSELK KVRSNSRIYH RYFLLDADMQ SLRWEPSKKD
     SEKAKIDIKS IKEVRTGKNT DIFRSNGISD QISEDCAFSV IYGENYESLD LVANSADVAN
     IWVTGLRYLI SYGKHTLDML ESSQDNMRTS WVSQMFSEID VDNLGHITLC NAVQCIRNLN
     PGLKTSKIEL KFKELHKSKD KAGTEVTKEE FIEVFHELCT RPEIYFLLVQ FSSNKEFLDT
     KDLMMFLEAE QGVAHINEEI SLEIIHKYEP SKEGQEKGWL SIDGFTNYLM SPDCYIFDPE
     HKKVCQDMKQ PLSHYFINSS HNTYLIEDQF RGPSDITGYI RALKMGCRSV ELDVWDGPDN
     EPVIYTGHTM TSQIVFRSVI DIINKYAFFA SEYPLILCLE NHCSIKQQKV MVQHMKKLLG
     DKLYTTSPNV EESYLPSPDV LKGKILIKAK KLSSNCSGVE GDVTDEDEGA EMSQRMGKEN
     MEQPNNVPVK RFQLCKELSE LVSICKSVQF KEFQVSFQVQ KYWEVCSFNE VLASKYANEN
     PGDFVNYNKR FLARVFPSPM RIDSSNMNPQ DFWKCGCQIV AMNFQTPGLM MDLNIGWFRQ
     NGNCGYVLRP AIMREEVSFF SANTKDSVPG VSPQLLHIKI ISGQNFPKPK GSGAKGDVVD
     PYVYVEIHGI PADCAEQRTK TVHQNGDAPI FDESFEFQIN LPELAMVRFV VLDDDYIGDE
     FIGQYTIPFE CLQTGYRHVP LQSLTGEVLA HASLFVHVAI TNRRGGGKPH KRGLSVRKGK
     KSREYASLRT LWIKTVDEVF KNAQPPIRDA TDLRENMQNA VVSFKELCGL SSVANLMQCM
     LAVSPRFLGP DNTPLVVLNL SEQYPTMELQ GIVPEVLKKI VTTYDMMIQS LKALIENADA
     VYEKIVHCQK AAMEFHEHLH SIGTKEGLKE RKLQKAVESF TWNITILKGQ ADLLKYAKNE
     TLENLKQIHF AAVSCGLNKP GTENADVQKP RRSLEVIPEK ANDETGE
//
